Literature DB >> 21312416

Molecules, signaling, and schizophrenia.

Mirna Kvajo1, Heather McKellar, Joseph A Gogos.   

Abstract

Schizophrenia is one of the most common psychiatric disorders, but despite some progress in identifying the genetic factors implicated in its development, the molecular mechanisms underlying its etiology and pathogenesis remain poorly understood. However, accumulating evidence suggests that regardless of the underlying genetic complexity, the mechanisms of the disease may impact a small number of common signaling pathways. In this review, we discuss the evidence for a role of schizophrenia susceptibility genes in intracellular signaling cascades by focusing on three prominent candidate genes: AKT, PPP3CC (calcineurin), and DISC1. We describe the regulation of a number of signaling cascades by AKT and calcineurin through protein phosphorylation and dephosphorylation, and the recently uncovered functions of DISC1 in cAMP and GSK3beta signaling. In addition, we present independent evidence for the involvement of their downstream signaling pathways in schizophrenia. Finally, we discuss evidence supporting an impact of these susceptibility genes on common intracellular signaling pathways and the convergence of their effects on neuronal processes implicated in schizophrenia.

Entities:  

Mesh:

Year:  2010        PMID: 21312416     DOI: 10.1007/7854_2010_41

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  20 in total

Review 1.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

2.  The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion.

Authors:  Karine Fénelon; Bin Xu; Cora S Lai; Jun Mukai; Sander Markx; Kimberly L Stark; Pei-Ken Hsu; Wen-Biao Gan; Gerald D Fischbach; Amy B MacDermott; Maria Karayiorgou; Joseph A Gogos
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways.

Authors:  A Chakraborty; C Latapy; J Xu; S H Snyder; J-M Beaulieu
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

Review 4.  The potential of biomarkers in psychiatry: focus on proteomics.

Authors:  Izabela Sokolowska; Armand G Ngounou Wetie; Kelly Wormwood; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

Review 5.  Towards medication-enhancement of cognitive interventions in schizophrenia.

Authors:  Hsun-Hua Chou; Elizabeth Twamley; Neal R Swerdlow
Journal:  Handb Exp Pharmacol       Date:  2012

6.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

7.  Diverse types of genetic variation converge on functional gene networks involved in schizophrenia.

Authors:  Sarah R Gilman; Jonathan Chang; Bin Xu; Tejdeep S Bawa; Joseph A Gogos; Maria Karayiorgou; Dennis Vitkup
Journal:  Nat Neurosci       Date:  2012-11-11       Impact factor: 24.884

Review 8.  Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.

Authors:  M Kvajo; H McKellar; J A Gogos
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

Review 9.  Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis.

Authors:  Andrew M Rosen; Timothy Spellman; Joshua A Gordon
Journal:  Biol Psychiatry       Date:  2015-03-27       Impact factor: 13.382

10.  Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness.

Authors:  Gregg W Crabtree; Ziyi Sun; Mirna Kvajo; Jantine A C Broek; Karine Fénelon; Heather McKellar; Lan Xiao; Bin Xu; Sabine Bahn; James M O'Donnell; Joseph A Gogos
Journal:  J Neurosci       Date:  2017-03-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.